跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HPV-9
首页
药物
HPV-9
HPV-9
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
LOPINAVIR AND RITONAVIR FOR THE TREATMENT OF CERVIX DISORDERS
EP 3801509 A1
申请人: DOUGLAS PHARMACEUTICALS LTD
优先权: 2018
CN
EP
US
4 件公开
Use of oligomers of lactic acid in the treatment of gynaecological disorders
US 8425894 B2
申请人: BATCHELLER GREG
优先权: 2007
CN
US
3 件公开
Method of detecting new immunogenic T cell epitopes and isolating new antigen-specific T cell receptors by means of an MHC cell library
US 11001830 B2
申请人: MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN HELMHOLTZ GEMEINSCHAFT
优先权: 2015
CN
US
3 件公开
Detection method for cervical HPVS
US 9435001 B2
申请人: MEIJER CHRISTOPHORUS JOANNES LAMBERTUS MARIA
优先权: 2007
US
Antigen epitope minimum motif peptide of human papilloma virus 58 type E6 protein
CN 101696231 B
申请人: LIU RITING
优先权: 2009
CN
Pharmaceutical composition for treating condyloma acuminatum
CN 105362475 A
申请人: ZHONG ZHULIN
优先权: 2015
CN
Preparation method of human papillomavirus inhibition gel
CN 107353416 A
申请人: XIONG TINGZHEN
优先权: 2017
CN
Chinese medicinal preparation for eliminating HPV infection and preparation method thereof
CN 109200235 A
申请人: ZHANG JIANQING
优先权: 2018
CN
Traditional Chinese medicine biological preparation with inhibiting effect on HPV and hysteromyoma and preparation method
CN 112618653 A
申请人: SHANDONG LIDA BIOTECHNOLOGY GROUP CO LTD
优先权: 2020
CN
Calreticulin combined peptide and application thereof
CN 112898401 A
申请人: HEFEI RUICHENGSHENG BIOTECHNOLOGY CO LTD
优先权: 2021
CN
第 1 / 3 页
上一页
下一页
药物
反馈